Form 4: Pediatrix Medical Group CEO Mark Ordan Reports Stock Transaction
SEC Form 4 Filing
CEO Mark Ordan reports disposition of shares to cover tax obligations upon vesting.
Summary
- On May 9, 2025, Mark S Ordan, CEO of Pediatrix Medical Group, Inc., reported a transaction involving common stock.
- 7,225 shares were disposed of to cover tax obligations upon vesting at a price of $14.44 per share.
- Following the transaction, Ordan directly owns 131,458 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a standard transaction related to tax obligations.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of transaction |
| 05/12/2025 | Date of signature |
Keywords
Form 4, Pediatrix Medical Group, Mark Ordan, CEO, Stock Transaction, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.